Satsuma Pharmaceuticals

Share on: 
Description: 

STS101 is Satsuma's lead product candidate.  STS101 is a potential therapy for migraine that combines the anti-migraine drug, dihydroergotamine (DHE), with a dry-powder nasal formulation and drug delivery device.

Career Page(s): 
Location(s): 
South San Francisco CA
United States